Clinical Trial Update: Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Live Birth Rate between PPOS and GnRH antagonist protocols in patients with anticipated high ovarian response in IVF.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• GnRH antagonist protocol (Gonadotropin-releasing hormone antagonist protocol)
• PPOS (not specified)

Snippet

Sponsor: ShangHai Ji Ai Genetics & IVF Institute | Conditions: IVF, GnRH Antagonist | Phase 3 | Status: COMPLETED